Back to Search
Start Over
Salvage High-Dose Chemotherapy for Relapsed Pure Seminoma in the Last 10 Years: Results From the European Society for Blood and Marrow Transplantation Series 2002-2012
- Source :
- Clinical Genitourinary Cancer; February 2017, Vol. 15 Issue: 1 p163-167, 5p
- Publication Year :
- 2017
-
Abstract
- In a retrospective analysis of data from 13 European Society for Blood and Marrow Transplantation (EBMT) centers, we evaluated the contemporary outcomes of high-dose chemotherapy (HDCT) as salvage therapy of advanced seminoma. The results supported the use of HDCT, particularly for patients with chemosensitive disease. This proof of concept needs to be prospectively validated in a randomized trial of HDCT versus standard-dose chemotherapy.
Details
- Language :
- English
- ISSN :
- 15587673
- Volume :
- 15
- Issue :
- 1
- Database :
- Supplemental Index
- Journal :
- Clinical Genitourinary Cancer
- Publication Type :
- Periodical
- Accession number :
- ejs39458571
- Full Text :
- https://doi.org/10.1016/j.clgc.2016.06.013